AMTD Digital (HKD) had the highest return between June 6, 2022 and July 30, 2022 by a small-cap US stock, returning 2,978.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
AMTD Digital (HKD) | 6/6/2022 - 7/30/2022 | 2,978.85% |
Next Technology (NXTT) | 6/6/2022 - 7/30/2022 | 333% |
NuCana (NCNA) | 6/6/2022 - 7/30/2022 | 190.63% |
Getty Images (GETY) | 6/6/2022 - 7/30/2022 | 162.55% |
Cogent Biosciences (COGT) | 6/6/2022 - 7/30/2022 | 149.21% |
Day One Biopharmaceuticals (DAWN) | 6/6/2022 - 7/30/2022 | 140.93% |
Amylyx Pharmaceuticals (AMLX) | 6/6/2022 - 7/30/2022 | 124.54% |
Dyne Therapeutics (DYN) | 6/6/2022 - 7/30/2022 | 122.25% |
Altimmune (ALT) | 6/6/2022 - 7/30/2022 | 120.77% |
Kura Sushi USA (KRUS) | 6/6/2022 - 7/30/2022 | 115.57% |
Yatsen (YSG) | 6/6/2022 - 7/30/2022 | 114.52% |
Target Hospitality (TH) | 6/6/2022 - 7/30/2022 | 99.85% |
Avadel Pharmaceuticals (AVDL) | 6/6/2022 - 7/30/2022 | 95.45% |
Skywater Technology (SKYT) | 6/6/2022 - 7/30/2022 | 93.38% |
Eos Energy Enterprises (EOSE) | 6/6/2022 - 7/30/2022 | 92.12% |
Vigil Neuroscience (VIGL) | 6/6/2022 - 7/30/2022 | 90.54% |
Advent Technologies (ADNWW) | 6/6/2022 - 7/30/2022 | 83.2% |
CorMedix (CRMD) | 6/6/2022 - 7/30/2022 | 80.13% |
Cidara Therapeutics (CDTX) | 6/6/2022 - 7/30/2022 | 74.44% |
Uniqure (QURE) | 6/6/2022 - 7/30/2022 | 65.58% |
Compass Pathways (CMPS) | 6/6/2022 - 7/30/2022 | 65.32% |
Verve Therapeutics (VERV) | 6/6/2022 - 7/30/2022 | 64.57% |
Clene (CLNNW) | 6/6/2022 - 7/30/2022 | 63.27% |
Beam Therapeutics (BEAM) | 6/6/2022 - 7/30/2022 | 62.87% |
Aldeyra (ALDX) | 6/6/2022 - 7/30/2022 | 61.02% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
